Semi-Annual Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7262351

Concept 2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
As at
2025-02-28
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
As at
2024-02-29
As at
2023-02-28
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
21,190,000,000 JPY
28,687,000,000 JPY
19,186,000,000 JPY
13,765,000,000 JPY
Depreciation
6,185,000,000 JPY
5,110,000,000 JPY
Impairment losses
343,000,000 JPY
847,000,000 JPY
Amortization of goodwill
150,000,000 JPY
62,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
83,000,000 JPY
-14,000,000 JPY
Interest and dividend income
-3,993,000,000 JPY
-3,684,000,000 JPY
Interest expenses
23,000,000 JPY
18,000,000 JPY
Increase (decrease) in retirement benefit liability
-9,000,000 JPY
193,000,000 JPY
Foreign exchange losses (gains)
-109,000,000 JPY
-780,000,000 JPY
Increase (decrease) in provision for bonuses
325,000,000 JPY
468,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
-590,000,000 JPY
-585,000,000 JPY
Decrease (increase) in trade receivables
-2,525,000,000 JPY
-2,082,000,000 JPY
Decrease (increase) in inventories
-347,000,000 JPY
-1,628,000,000 JPY
Increase (decrease) in trade payables
-2,642,000,000 JPY
686,000,000 JPY
Other, net
-736,000,000 JPY
-87,000,000 JPY
Subtotal
18,610,000,000 JPY
18,474,000,000 JPY
Interest and dividends received
4,467,000,000 JPY
3,757,000,000 JPY
Interest paid
-25,000,000 JPY
-18,000,000 JPY
Income taxes paid
-4,279,000,000 JPY
-4,017,000,000 JPY
Net cash provided by (used in) operating activities
18,765,000,000 JPY
18,188,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-13,627,000,000 JPY
-12,924,000,000 JPY
Proceeds from sale of property, plant and equipment
154,000,000 JPY
186,000,000 JPY
Purchase of investment securities
-511,000,000 JPY
-15,000,000 JPY
Proceeds from collection of loans receivable
1,000,000 JPY
2,000,000 JPY
Other, net
JPY
25,000,000 JPY
Net cash provided by (used in) investing activities
17,563,000,000 JPY
-2,512,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,830,000,000 JPY
JPY
Repayments of long-term borrowings
-217,000,000 JPY
-66,000,000 JPY
Purchase of treasury shares
-10,554,000,000 JPY
-9,796,000,000 JPY
Dividends paid
-6,519,000,000 JPY
-6,578,000,000 JPY
Net cash provided by (used in) financing activities
-15,850,000,000 JPY
-16,691,000,000 JPY
Dividends paid to non-controlling interests
-216,000,000 JPY
-111,000,000 JPY
Other, net
-172,000,000 JPY
-133,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
2,936,000,000 JPY
1,957,000,000 JPY
Net increase (decrease) in cash and cash equivalents
23,414,000,000 JPY
941,000,000 JPY
Cash and cash equivalents
89,780,000,000 JPY
66,366,000,000 JPY
65,424,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.